Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma.
about
In vivo models of primary brain tumors: pitfalls and perspectives.Maximizing safe resection of low- and high-grade glioma.Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme: a phase II study.Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastomaChemotherapy for high-grade gliomas.Early toxicity predicts long-term survival in high-grade glioma.The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme.CNS Anticancer Drug Discovery and Development Conference White Paper.Lack of EGF receptor contributes to drug sensitivity of human germline cellsGlioma extent of resection and its impact on patient outcome.Randomized Phase III controlled trials of therapy in malignant glioma: where are we after 40 years?The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patientsOperative techniques for gliomas and the value of extent of resection.The value of glioma extent of resection in the modern neurosurgical era.Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival.A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma.Impact of p53 status to response of temozolomide in low MGMT expression glioblastomas: preliminary results.Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas.Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expression.ONC201: a new treatment option being tested clinically for recurrent glioblastoma
P2860
Q26862847-F15EA74D-0E02-45F1-9876-C6F884C676CAQ31095748-3E0A780F-2B14-4DA5-B6C2-A89FC09985EEQ33501488-89841C4B-E135-4ED2-BA2C-58AE11AA00DDQ33708309-8328939C-2C44-4B38-B643-23F20FBCD53FQ33898570-9093612B-268C-4894-8E88-F1C558D0C099Q35006910-6E96A9C1-BF2E-44B1-A6B6-EF45717E680DQ35688316-22BDE310-E0EC-4318-8607-C7F3EF5E576DQ36089590-D6241926-90F9-4734-944F-09FD94C5D2ACQ36616189-99F0E26D-B212-482A-B72C-C8ECF0C7FF55Q37170201-0EAB0E0C-C188-4BBA-BA10-73E0EA64B2BDQ37196375-91D62ACF-475A-41A6-8A6A-E0C81BC9D618Q37475929-EC497F34-2A56-43EE-B2D6-AC89D0C18EA9Q37533640-48E8CB0B-B041-4488-A5DA-412E0901BE6CQ38054083-ED538FA2-8749-4B24-9DEB-0972F2CB944EQ39264053-A5CF6C25-0436-4F60-94DE-8C645964E56BQ40599312-F294E95B-4FB7-45F6-99CF-720CFFA0D5D4Q46468735-708CF029-B991-4284-B36E-54796D016A01Q48598106-3236181D-CC3C-4BB2-8AE9-8248CC3E7B2DQ55476767-90AA59C3-9E43-499D-8AEE-8C4828911BA7Q55980927-9DA41295-D5BB-49FA-8603-CB89EAB46119
P2860
Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma.
description
1993 nî lūn-bûn
@nan
1993 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Phase III comparative evaluati ...... therapy for high-grade glioma.
@ast
Phase III comparative evaluati ...... therapy for high-grade glioma.
@en
type
label
Phase III comparative evaluati ...... therapy for high-grade glioma.
@ast
Phase III comparative evaluati ...... therapy for high-grade glioma.
@en
prefLabel
Phase III comparative evaluati ...... therapy for high-grade glioma.
@ast
Phase III comparative evaluati ...... therapy for high-grade glioma.
@en
P2093
P1476
Phase III comparative evaluati ...... therapy for high-grade glioma.
@en
P2093
B W Scheithauer
J C Buckner
J R O'Fallon
L K Tschetter
R M Arusell
R P Dinapoli
P304
P356
10.1200/JCO.1993.11.7.1316
P407
P577
1993-07-01T00:00:00Z